Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963–966.
Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet, physical activity and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995;87:652–661.
Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCap tumors in nude mice fed a low fat diet. J Natl Cancer Inst 1995;87:1456–1462.
Pollard M, Luckert PH. Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 1986;32:223–227.
Bosland MC, Dreef van der Meulen HC, Scherrehberg PM. Effect of dietary fat on rat prostate carcinogenesis induced by N-methyl-N-nitrosurea and testosterone. Proc Am Assoc Cancer Res 1990;31:144.
Pour PM, Groot K, Kazakoff K, Anderson K, Schally AV. Effects of high-fat diet on the patterns of prostate cancer induced in rats by N-nitrosobis (2-oxopropyl)amine and testosterone. Cancer Res 1991;51:4757–4761.
Clinton SK, Palmer SS, Spriggs CE, Visek WJ. Growth of Dunning transplantable prostate adenocarcinomas in rats fed diets with venous fat content. J Nutr 1988;118:908–914.
Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ, Clinton SK. Energy intake and prostate tumour growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 1999;91:512–523.
Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption. Cancer 1986;58:2363–2371.
Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer: geographical distribution and time trends. Acta Oncol 1991;30:133–140.
Bairati I, Meyer F, Fradet Y, Moore L. Dietary fat and advanced prostate cancer. J Urol 1998;159:1271–1275.
Hankin JH, Zhao LP, Wilkens LR, Kolonel LN. Attributable risk of breast, prostate, and lung cancer in Hawaii due to saturated fat. Cancer Causes Control 1992;3:17–23.
Snowdon DA, Phillips RL, Choi W. Diet, obesity and risk of fatal prostate cancer. Am J Epidemiol 1984;120:244–250.
Severson RK, Nomura AM, Grove JS, Stemmermann GN. A prospective study of demographics, diet and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989;49:1857–1860.
Schuurman AG, van den Brandt PA, Dorant E, Brants HA, Goldbohm RA. Association of energy and fat intake with prostate cancer risk: results from the Netherlands Cohort Study. Cancer 1999;86:1019–1027.
Giovannucci E, Rimm EB, Colditz GA, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993;85:1571–1579.
Godley PA, Campbell MK, Gallagher P, Martinson FE, Mohler JL, Sander RS. Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev 1996;5:889–895.
Ramon JM, Bou R, Romea S, et al. Dietary fat intake and prostate cancer risk: a case-control study in Spain. Cancer Causes Control 2000;11:679–685.
Pandalai PK, Pilat MJ, Yamazaki K, Naik H, Pienta KJ. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res 1996;16:815–820.
Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 1994;5:276–282.
Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 1994;89:281–286.
Fleshner N, Fair WR, Huryk R, Heston WD. Vitamin E inhibits the high-fat promoted growth of established human prostate LNCaP tumours in nude mice. J Urol 1999;161:1651–1654.
Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alphatocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1990;90:440–446.
Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 1999;8:893–899.
Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992;70:2861–2869.
Habuchi T, Suzuki T, Sasaki R et al. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res 2000;60:305–308.
Konety BR, Johnson CS, Trump DL, Getzenberg RH. Vitamin D in the prevention and treatment of prostate cancer. Semin Urol Oncol 1999;17:77–84.
Giovannucci E, Rimm EB, Wolk A, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998;58:442–447.
Grant WB. An ecological study of dietary links to prostate cancer. Altern Med Rev 1999;4:162–169.
Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiological literature. J Natl Cancer Inst 1999;91:317–331.
Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989;64:598–604.
Schulman CC, Ekane S, Zlotta AR. Nutrition and prostate cancer: evidence or suspicion? Urology 2001;58:318–334.
Hirayama T. Epidemiology of prostate cancer with special reference to the role of diet. Natl Cancer Inst Monogr 1979;53:149–155.
Webber MM, Perez-Ripoll EA, James GT. Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro. Biochem Biophys Res Commun 1985;130:603–609.
Yang M, Sytkowski AJ. Differential expression and androgen regulation of the human selenium-binding protein gene hSP56 in prostate cancer cells. Cancer Res 1998;58:3150–3153.
Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998;81:730–734.
Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toe nails and risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219–1224.
Davis JN, Singh B, Bhuiyan M, Sarkar FH. Genistein-induced upregulation of p21WAF 1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer 1998;32:123–131.
Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592–5595.
Aronson WJ, Tymchuk CN, Elashoff RM, et al. Decreased growth of human prostate LNCaP tumours in SCID mice fed to a low-fat, soy protein diet with isoflavones. Nutr Cancer 1999;35:130–136.
Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl JS. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst 1998;90:1637–1647.
Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cells by tea polyphenols. Carcinogenesis 1998;19:611–616.
Mohan RR, Challa A, Gupta S, et al. Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. Clin Cancer Res 1999;5:143–147.
Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res 1999;59:2115–2120.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag London Limited
About this chapter
Cite this chapter
Mazhar, D. (2005). Diet and Prostate Cancer. In: Waxman, J. (eds) Urological Cancers. Springer, London. https://doi.org/10.1007/1-84628-015-X_4
Download citation
DOI: https://doi.org/10.1007/1-84628-015-X_4
Publisher Name: Springer, London
Print ISBN: 978-1-85233-911-1
Online ISBN: 978-1-84628-015-3
eBook Packages: MedicineMedicine (R0)